Kinetics of cerebral blood flow velocities during treatment for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage
Autor: | Feres Chaddad, Gisele Sampaio Silva, Carolina Rouanet, Flávio Geraldo Resende Freitas, Maramelia Miranda, Natalia Vasconcellos, Raul Alberto Valiente, Susanne Muehlschlegel |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Mean arterial pressure Subarachnoid hemorrhage business.industry Ischemia Vasospasm Blood flow Subarachnoid Hemorrhage Critical Care and Intensive Care Medicine medicine.disease Brain Ischemia Transcranial Doppler Kinetics Cerebral blood flow Internal medicine medicine Cardiology Humans Vasospasm Intracranial Milrinone Prospective Studies Neurology (clinical) business Blood Flow Velocity medicine.drug |
Zdroj: | Neurocritical Care. 36:226-239 |
ISSN: | 1556-0961 1541-6933 |
Popis: | In aneurysmal subarachnoid hemorrhage (aSAH), one of the main determinants of prognosis is delayed cerebral ischemia (DCI). Transcranial Doppler (TCD) is used to monitor vasospasm and DCI. We aimed to better understand cerebral hemodynamics response to hypertension induction (HI) with norepinephrine (NE) and inotropic therapy with milrinone so that TCD can be a bedside tool in helping to guide DCI therapies. Our primary objective was to determine TCD blood flow velocity (BFV) kinetics during HI and inotropic therapy for DCI treatment. Secondly, we performed an analysis by treatment subgroups and evaluated clinical response to therapies. We performed a prospective observational cohort study in a Brazilian high-volume center for aSAH. Patients with aSAH admitted between 2016 and 2018 who received NE or milrinone for DCI treatment were included. TCDs were performed before therapy initiation (t0) and 45 (t1) and 90 min (t2) from the onset of therapy. For each DCI event, we analyzed the highest mean flow velocity (MFV) and the mean MFV and compared their kinetics over time. The National Institutes of Health Stroke Scale was determined at t0, t1, and t2. Ninety-eight patients with aSAH were admitted during the study period. Twenty-one (21.4%) developed DCI, of whom six had DCI twice, leading to a total of 27 analyzed DCI events (12 treated with HI and 15 with milrinone). Patients treated with NE had their mean arterial pressure raised (85 mm Hg in t0, 112 mm Hg in t2 [p |
Databáze: | OpenAIRE |
Externí odkaz: |